Clik here to view.
Spectral Medical’s Toraymyxin fails pivotal trial
A clinical trial of the Toraymyxin anti-sepsis device made by Spectral Medical (TSX:EDT) failed to meet its primary endpoint, sending share prices on a -81.1% plunge today. Toronto-based Spectral...
View ArticleClik here to view.
ConvaTec IPO could fetch nearly $2B
ConvaTec said today that it plans to raise about $1.8 billion in an initial public offering on the London Stock Exchange in the largest U.K. flotation this year, even as Great Britain prepares to exit...
View ArticleClik here to view.
Medtronic touts 1-year data on Avalus surgical aortic valve
Medtronic (NYSE:MDT) today reported 1-year results from a clinical trial of its Avalus pericardial aortic surgical valve, touting low rates of adverse valve-related events and high survival numbers....
View ArticleClik here to view.
Narrative of New ISO 10993-1 Standard – Part 1: “Evaluation and testing...
By Laurence Lister, Department Head, Biocompatibility Services The big topic in biocompatibility this year is the release of the much anticipated final version of, “Use of International Standard ISO...
View ArticleClik here to view.
Analyst: Insulet’s drug-delivery biz a long-term growth driver
Insulet’s (NSDQ:PODD) drug-delivery business will be a long-term growth driver for the company by as much as 20% a year for the next few years, according to Leerink Partners analysts. Billerica,...
View ArticleClik here to view.
Edwards Lifesciences wins CE Mark for Acumen hypotension monitor
Edwards Lifesciences (NYSE:EW) said today that it won CE Mark approval in the European Union for its Acumen hypotension probability indicator. The newly cleared Acumen monitor is designed to alert...
View ArticleClik here to view.
FDA approves label changes for GE’s Optison
GE Healthcare (NYSE:GE) announced today that the FDA approved label changes for its ultrasound contrast agent Optison, removing contraindications for use in patients with cardiac shunts and for...
View ArticleClik here to view.
Angel Valve Project seeks $15m for Mitral Butterfly device
Medical University Vienna spin-off Angel Valve Project said today it raised $224,370 (EU €200,000) in preseed investments and is looking for another $14.6 million to support its Mitral Butterfly...
View ArticleClik here to view.
Novo Nordisk eyes drug development program
Novo Nordisk (NYSE:NVO) is betting on a risky drug development strategy, like re-engineering insulin to act selectively on the liver or only when blood sugar is high, according to the Wall Street...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 3, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
NeoTract touts reimbursement win for UroLift
NeoTract today touted a reimbursement win from Geisinger Health Plan and EmblemHealth that will allow coverage for procedures using its UroLift system for patients with benign prostatic hyperplasia....
View ArticleClik here to view.
Hospital researchers explore MRI for drug delivery
Researchers have programmed an MRI scanner to simultaneously monitor magnetized particles while propelling them through blood vessels as a means to locally deliver drugs. Existing approaches combine...
View ArticleClik here to view.
NxStage inks home hemodialysis deal with Satellite Health
NxStage Medical (NSDQ:NXTM) said today it inked a 3-year home hemodialysis supply agreement with Satellite Healthcare. Satellite, a non-profit group, is the 6th-largest dialysis and kidney disease...
View ArticleClik here to view.
FDA approves Valencia’s eCoin neurostim trial
Valencia Technologies said today it won investigational device exemption approval from the FDA to begin a trial of its eCoin neurostimulator for treating drug-resistant hypertension. The company is...
View ArticleClik here to view.
Japanese scientist wins Nobel medicine prize for work on “self-eating” cell...
(Reuters) – Japan’s Yoshinori Ohsumi won the 2016 Nobel prize for medicine for ground-breaking experiments with yeast which exposed a key mechanism in the body’s defenses where cells degrade and...
View ArticleClik here to view.
Johnson & Johnson warns on low cyber risk with Animas OneTouch Ping insulin pump
Johnson & Johnson (NYSE:JNJ) is reportedly warning patients of a small risk that hackers will target its Animas OneTouch Ping insulin pump, after learning of the bug causing the potential...
View ArticleClik here to view.
Boston Scientific loses bid to toss $19m pelvic mesh loss
Boston Scientific (NYSE:BSX) yesterday lost its bid to overturn an $18.5 million loss in a product liability lawsuit brought by a quartet of women alleging that its Obtryx pelvic mesh caused their...
View ArticleClik here to view.
FDA approves St. Jude Medical’s BurstDR spinal cord stimulation for chronic pain
St. Jude Medical (NYSE:STJ) said today that the FDA granted pre-market approval for its BurstDR spinal cord stimulation technology, which is designed to mimic the body’s natural nerve-firing patterns...
View ArticleClik here to view.
Committee pens letter to Mylan demanding EpiPen price info
Members of the U.S. House Committee on Oversight & Government Reform penned a letter to Mylan (NSDQ:MYL) demanding a more complete look at the pricing of its EpiPen epinephrine auto-injector. At a...
View ArticleClik here to view.
Color-changing wearable tracks sun exposure
Researchers have developed a wearable patch that warns users by changing colors when they’ve had too much sun exposure. Striking a balance between too much and too little sun exposure can be...
View Article
